Senior/Principal Bioprocess Engineer at Eli Lilly and Company

Limerick, County Limerick, Ireland

Eli Lilly and Company Logo
$60,000 – $90,000Compensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biopharmaceuticals, Bioprocessing, Chemical EngineeringIndustries

Skills

Key technologies and capabilities for this role

Mammalian Cell CultureFermentationDownstream ProcessingScale-upTechnology TransferGMPcGMPProcess SafetySOPsOperational Readiness PlanVerification ActivitiesTech TransferUser RequirementsC&Q

Questions & Answers

Common questions about this position

What is the salary for the Senior/Principal Bioprocess Engineer position?

This information is not specified in the job description.

Is this role remote or does it require working on-site?

The position is based at the Limerick, Ireland site.

What key experiences are required for this bioprocess engineering role?

Required experiences include facility start-up, Process Safety Assessments, C&Q support, SOP development, automation optimization, and tech transfer of new processes.

What is the company culture like at Eli Lilly?

Eli Lilly prioritizes people, strives to make a positive impact on the world, and unites caring with discovery to improve lives, while utilizing next-generation technologies.

What makes a candidate stand out for this Senior/Principal Bioprocess Engineer role?

Candidates with experience levels commensurate for Senior or Principal roles, particularly in facility start-up, tech transfer, and leveraging learnings from prior projects, will be strongest.

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI